Rigel Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc. (RIGL) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RIGL · as of Jun 8, 2026
Key Statistics
Explore Rigel Pharmaceuticals, Inc. Data
rigl stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 15 · Buy rate: 53.3%
The RIGL analyst consensus is Buy, based on ratings from 15 Wall Street analysts over the past 3 months. The average 12-month price target is $27.33, representing -9.14% downside from the current price of $30.08.
Competitors & Peers
rigl competitorsRIGL
AKBA
BCYC
CRVS
FDMT
GOSSStock Performance
Full HistoryAbout Rigel Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc. is a biotechnology company dedicated to discovering and developing small molecule therapies. The firm's focus areas include hematologic disorders, oncology, and rare immune…
what is rigel pharmaceuticals, inc. · rigl stock overview · rigel pharmaceuticals, inc. company profile · who is rigel pharmaceuticals, inc. ceo · rigl NASDAQ · rigel pharmaceuticals, inc. headquarters · rigel pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Rigel Pharmaceuticals, Inc. (RIGL) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 29, 2000. As of the latest trading session, RIGL stock price is $30.08, with a market capitalization of $556.5M. The stock has returned +37.57% over the past 12 months and -29.82% year-to-date.
According to 15 Wall Street analysts, the consensus rating for Rigel Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $27.33. In fiscal year 2025, Rigel Pharmaceuticals, Inc. reported revenue of $294.3M and net income of $367.0M. For detailed data — including Rigel Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Rigel Pharmaceuticals, Inc. (RIGL) stock price is $30.08. The stock is traded on NASDAQ under the ticker symbol RIGL. The 52-week range is $18.14 – $52.24.